Pharmsintez reported for 6 months of 2024 by RAS

Pharmsintez's RAS loss for 6 months of 2024 amounted to ₽74.31 million, down 46.2% from ₽138 million in the previous year. Revenue declined 19.8% to ₽102.24 million from ₽127.53 million a year earlier.